A Systematic Review of Cost Effectiveness of Pembrolizumab Versus Standard Treatment for Metastatic Non-Small Cell Lung Cancer

2021 ◽  
Vol 13 (02) ◽  
Keyword(s):  
Lung Cancer ◽  
Systematic Review ◽  
Cost Effectiveness ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Standard Treatment ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)

2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Ansgar Lange ◽  
Anne Prenzler ◽  
Martin Frank ◽  
Heiko Golpon ◽  
Tobias Welte ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Systematic Review ◽  
Cost Effectiveness ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Targeted Therapies ◽  
Small Cell ◽  
Small Cell Lung ◽  
The Cost

scholarly journals Cost effectiveness of immune checkpoint inhibitors for treatment of non-small cell lung cancer: A systematic review

PLoS ONE ◽  
2020 ◽  
Vol 15 (9) ◽  
pp. e0238536 ◽  
Author(s):  
Haiying Ding ◽  
Wenxiu Xin ◽  
Yinghui Tong ◽  
Jiao Sun ◽  
Gaoqi Xu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Systematic Review ◽  
Cost Effectiveness ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitors ◽  
Checkpoint Inhibitors ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document